Clinical Data, Inc. Launches Pharmacogenetic Warfarin Response Test On Schedule
NEWTON, Mass.--(BUSINESS WIRE)--Clinical Data, Inc. (NASDAQ: CLDA), announced today that its PGxHealth™ division, a provider of Therapeutic Diagnostics™, has launched its PGxTest:WARFARIN™